Explainable Multilayer Graph Neural Network for cancer gene prediction

Michail Chatzianastasis1, Michalis Vazirgiannis1, Zijun Zhang2

  • 1LIX, École Polytechnique, IP Paris, Rte de Saclay, Palaiseau, 91120, France.

PubMed
Abstract

Insights

Explainable Multilayer Graph Neural Networks (EMGNN) identify cancer genes by integrating multiple gene interaction networks and multi-omics data. This approach improves prediction accuracy and provides biological insights, outperforming existing methods in cancer genomics research.

Area of Science:

  • Computational biology
  • Cancer genomics
  • Network science

Background:

  • Identifying cancer genes is crucial but challenging in cancer genomics.
  • Existing methods like deep graph neural networks struggle with multilayered gene interactions and lack explainability.
  • Single biological networks fail to capture the complexity of tumorigenesis, leading to inconsistent predictions.

Purpose of the Study:

  • To develop an Explainable Multilayer Graph Neural Network (EMGNN) for accurate cancer gene identification.
  • To leverage multiple gene-gene interaction networks and pan-cancer multi-omics data.
  • To provide explainable predictions and biological insights for identified cancer genes.

Main Methods:

  • Utilized a multilayered graph neural network architecture (EMGNN).
  • Integrated multiple gene-gene interaction networks and pan-cancer multi-omics data.
  • Incorporated model-level feature importance and molecular-level gene set enrichment analysis for explainability.

Main Results:

  • EMGNN achieved an average 7.15% improvement in area under the precision-recall curve compared to state-of-the-art methods.
  • Successfully prioritized newly predicted cancer genes with conflicting single-network predictions.
  • Provided valuable biological insights through explainable AI techniques.

Conclusions:

  • EMGNN offers a novel graph learning paradigm for cancer gene identification.
  • The method effectively models multilayered topological gene relationships.
  • EMGNN serves as a valuable tool for advancing cancer genomics research.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K